Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Betta Pharmaceuticals Co. Ltd.

en.bettapharma.com

Latest From Betta Pharmaceuticals Co. Ltd.

Breaking Away From Betta, Jacobio Raises China Oncology Development Bar

Emerging Company Profile: Founded by former executives of China’s national innovation darling Betta Pharma, Beijing-based Jacobio is focused on novel oncology assets, led by a KRAS inhibitor that's set to begin Phase I and IIa studies in the US and China for solid tumors.

StartUps and SMEs Cancer

Hepalink-Backed HighTide Bets On NASH For Global Markets

Emerging Company Profile: Fatty liver disease has been a hot development area that keeps getting more attention, and one Chinese startup backed by the world’s largest heparin manufacturer is looking to launch a new therapy globally.


China Liver & Hepatic

Venture Funding Deals: Recent Rounds For Gene-Editing Plays Top $300m

Gene-editing focused start-ups Beam Therapeutics, Gracell, Snipr Biome and Precision Biosciences raised a total of $310m in financings in February and March. For other recent venture funding deals... 
Deals Financing

Choose Carefully For China Drug Development Success: White Paper

By avoiding crowded space and focusing instead on therapeutic areas with large potential, China remains attractive for drug developers, notes a recent white paper from investment bank China E-Capital.

China Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • Zhejiang Beta Pharma Co. Ltd.
  • Beta Pharmaceutical Inc.
  • Zhejiang Beta Pharma Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Betta Pharmaceuticals Co. Ltd.
  • Senior Management
  • Lieming Ding, MD, CEO
  • Contact Info
  • Betta Pharmaceuticals Co. Ltd.
    Phone: 571 8613 0357
    355 Xingzhong Rd., Yuhang Economic Zone
    Hangzhou,
    China
UsernamePublicRestriction

Register